Peter Johann - Net Worth and Insider Trading
Peter Johann Net Worth
The estimated net worth of Peter Johann is at least $186 Million dollars as of 2024-04-27. Peter Johann is the Director of Horizon Therapeutics PLC and owns about 1,595,198 shares of Horizon Therapeutics PLC (HZNP) stock worth over $186 Million. Details can be seen in Peter Johann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Peter Johann has not made any transactions after 2011-08-02 and currently still holds the listed stock(s).
Transaction Summary of Peter Johann
Peter Johann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter Johann owns 1 companies in total, including Horizon Therapeutics PLC (HZNP) .
Click here to see the complete history of Peter Johann’s form 4 insider trades.
Insider Ownership Summary of Peter Johann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2011-08-02 | director & 10 percent owner |
Peter Johann Latest Holdings Summary
Peter Johann currently owns a total of 1 stock. Peter Johann owns 1,595,198 shares of Horizon Therapeutics PLC (HZNP) as of August 2, 2011, with a value of $186 Million.
Latest Holdings of Peter Johann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HZNP | Horizon Therapeutics PLC | 2011-08-02 | 1,595,198 | 116.30 | 185,521,527 |
Holding Weightings of Peter Johann
Peter Johann Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter Johann has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 194,639 shares on August 2, 2011, which cost Peter Johann around $2 Million.
Insider Trading History of Peter Johann
- 1
Peter Johann Trading Performance
GuruFocus tracks the stock performance after each of Peter Johann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter Johann is -4.2%. GuruFocus also compares Peter Johann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter Johann within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter Johann's insider trading performs compared to the benchmark.
Performance of Peter Johann
Average Return
-43.78%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.29 | -4.2 | -59.01 | -43.78 | -46.15 | -1.16 |
| Relative Return to S&P 500(%) | -1.9 | -2.91 | -64.71 | -52.6 | -62.89 | -16.52 |
Peter Johann Ownership Network
Ownership Network List of Peter Johann
Ownership Network Relation of Peter Johann
Peter Johann Owned Company Details
What does Horizon Therapeutics PLC do?
Who are the key executives at Horizon Therapeutics PLC?
Peter Johann is the director & 10 percent owner of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .
Horizon Therapeutics PLC (HZNP) Insider Trades Summary
Over the past 18 months, Peter Johann made no insider transaction in Horizon Therapeutics PLC (HZNP). Other recent insider transactions involving Horizon Therapeutics PLC (HZNP) include a net sale of 40,275 shares made by Jeffrey W Sherman , a net sale of 57,298 shares made by Andy Pasternak , and a net sale of 36,148 shares made by Aaron Cox .
In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 133,721 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,721 shares.
Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Horizon Therapeutics PLC Insider Transactions
Peter Johann Mailing Address
Above is the net worth, insider trading, and ownership report for Peter Johann. You might contact Peter Johann via mailing address: C/o Ngn Capital Bergheimer Str. 89a, Heidelberg 2m D69115.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
